Company intelligence / Profile preview

Russian Infar

Moscow, Moscow Oblast, Russia

Ownership: Private
Development stage: Other

Overview

Infar is a Russian pharmaceutical company focused on the development, manufacturing, and distribution of a wide range of medicinal products. The company specializes in essential medicines, including antibiotics, cardiovascular drugs, and treatments for gastrointestinal and neurological conditions. Infar operates manufacturing facilities that comply with local regulatory standards to supply the Russian healthcare market with affordable generic and branded medications. Their business model encompasses the full cycle from pharmaceutical development to large-scale production and market supply.

Therapeutic areas: GastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeBiologicVaccine
Industry: Biotech

Beyond the preview

Go deeper on Russian Infar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Russian Infar.

Explore the full profile